Adial Pharmaceuticals Inc (ADIL) — Financial Flexibility Index
Adial Pharmaceuticals Inc (ADIL) has a Financial Flexibility Index of -1.07x as of March 2026. Free cash flow of $-1.61 Million (operating CF $-1.61 Million minus capex $0.00) represents -1% of total liabilities ($1.51 Million). Check how strategically is Adial Pharmaceuticals Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Adial Pharmaceuticals Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Adial Pharmaceuticals Inc across 11 annual periods. See Adial Pharmaceuticals Inc (ADIL) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Adial Pharmaceuticals Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Adial Pharmaceuticals Inc. For the full company profile including market capitalisation, see market value of Adial Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.27x | $-6.49 Million | $-6.49 Million | $1.52 Million | ▲ +39.9% |
| 2024 | -7.09x | $-6.92 Million | $-6.92 Million | $975.86K | — |
| 2023 | 0.00x | $0.00 | $-6.81 Million | $653.51K | ▲ +100.0% |
| 2022 | -4.55x | $-11.19 Million | $-11.19 Million | $2.46 Million | ▼ -58.1% |
| 2021 | -2.88x | $-11.88 Million | $-11.95 Million | $4.13 Million | ▲ +42.7% |
| 2020 | -5.03x | $-7.57 Million | $-7.63 Million | $1.51 Million | ▲ +56.8% |
| 2019 | -11.64x | $-6.27 Million | $-6.34 Million | $539.05K | ▼ -23.4% |
| 2018 | -9.43x | $-2.43 Million | $-2.50 Million | $257.97K | ▼ -1867.6% |
| 2017 | -0.48x | $-494.86K | $-494.86K | $1.03 Million | ▲ +55.4% |
| 2016 | -1.08x | $-274.38K | $-274.38K | $255.02K | ▲ +87.7% |
| 2015 | -8.76x | $-465.22K | $-465.22K | $53.08K | — |